About the 2nd Awardee
The winner of the 2nd Terumo Global Science Prize is Dr. Sung Wan Kim, Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry and Distinguished Professor of Bioengineering, University of Utah. Dr.Kim's career and achievements are described below.
Dr. Sung Wan Kim
Date of Birth August 21, 1940
Career
- 1963
- B.S., Chemistry, Seoul National University, Korea
- 1965
- M.S., Physical Chemistry, Seoul National University, Korea
- 1969
- Ph.D., Chemistry, University of Utah, Thesis Supervisor, Professor Henry Eyring
- 1971
- Postdoctoral, Biomaterials - Institute for Biomedical Engineering and Department of Materials Science, University of Utah
- 1969 - 1971
- Research Associate, Department of Materials Science and Engineering and Institute for Biomedical Engineering, University of Utah
- 1971 - 1977
- Assistant Research Professor, Department of Materials Science and Engineering, University of Utah
- 1974 - 1977
- Assistant Professor, Department of Applied Pharmaceutical Sciences, University of Utah
- 1977 - 1980
- Associate Professor, Department of Pharmaceutics and Adjunct Associate Professor, Department of Bioengineering, University of Utah
- 1986 - 2006
- Director, Center for Controlled Chemical Delivery, University of Utah
- 1980 - 2000
- Professor, Department of Pharmaceutics and Pharmaceutical Chemistry, Adjunct Professor, Department of Bioengineering, University of Utah
- 2000 - present
- Distinguished Professor, Department of Pharmaceutics and Pharmaceutical Chemistry
- 2002 - present
- Distinguished Professor, Department of Bioengineering.
Dr. Sung Wan Kim is currently a Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry, and Bioengineering at the University of Utah. He is one of the pioneers in the areas of hydrogels, biodegradable drug conjugates, self-regulating drug delivery and stimuli sensitive polymers. He has published over 500 papers, received 35 U.S. Patents and trained over 130 scientists. He has been elected as the member of the Institute of Medicine of the National Academies (1999) and the National Academy of Engineering (2003). He had also served as a member of Gene and Drug Delivery Study Section at the National Institutes of Health (2006-2010).
Prize Records
- 1988
- The Clemson Basic Biomaterials Award
- 1995
- The Controlled Release Society (CRS) Founders Award
- 1998
- American Association of Pharmaceutical Scientists (AAPS) Dale Wurster Award
- 1999
- Elected Member in the Institute of Medicine of the National Academy of Sciences, USA
- 2002
- AACP Volwiler Award
- 2003
- Elected Member to the National Academy of Engineering, USA Rosenblatt Prize
- Ho-Am Prize
- 2004
- Research Achievement Award, Pharmaceutical Sciences World Congress
- 2006
- Received Honorary Doctor of Science, University of Twente, The Netherland
chievements and the Reasons for Prize Winning
A pioneer in the fields of biomaterials and drug delivery, Distinguished Professor Sung Wan Kim is a researcher who consistently garners cutting-edge results.
Dr. Kim worked with Dr. Willem Kolff, a University of Utah School of Medicine professor known for his research on the artificial heart, to develop the world's first antithrombotic materials with immobilized heparin, a polysaccharide that acts as an anticoagulant. This breakthrough opened up new possibilities for hybrid biomaterials combining natural and synthetic polymers.
Applying the same concept to the field of drug delivery, Dr. Kim successfully developed the world's first self-regulating insulin delivery system utilizing lectin specifically bound with glucose.
This intelligent drug delivery system with the ability to self-regulate required no external energy supply, an extraordinary breakthrough that dramatically improved subsequent drug delivery systems.
In the late 1990s, Dr. Kim embarked on research into polymeric gene hybridized artificial viruses.
The idea of wrapping genes in safe, avirulent polymers resolved the issue of immunoreaction posed by conventional viruses. With this groundbreaking research, Dr. Kim has been successful in delivering therapeutic genes to work on targeted areas inside the biological object.
The hybrid biomaterials and polymeric gene hybrid systems developed by Dr. Kim clearly demonstrate outstanding results from gene therapy not only in treating cancer and diabetes, but also in the field of regenerative medicine.
In this respect, Dr. Kim's research offers extraordinarily compelling results that link biomaterials, tissue engineering, and regenerative medicine.
Dr. Kim has also become a driving force in the field of biomaterials by dedicating his time to instructing many young researchers.
For these reasons, Professor Sung Wan Kim was chosen to receive the Second Terumo Global Science Prize.